Reply: Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs

Theodore J Iwashyna^{1

2

3}, James F Burke², Jeremy B Sussman^{2

3}, Hallie C Prescott^{2

3}, Rodney A Hayward^{2

3}, Derek C Angus⁴

Affiliations

Comment

Theodore J Iwashyna et al. Am J Respir Crit Care Med. 2015.

. 2015 Dec 1;192(11):1399-400.

doi: 10.1164/rccm.201508-1625LE.

Theodore J Iwashyna^{1

2

3}, James F Burke², Jeremy B Sussman^{2

3}, Hallie C Prescott^{2

3}, Rodney A Hayward^{2

3}, Derek C Angus⁴

No abstract available

Comment on

Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.
Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Iwashyna TJ, et al. Am J Respir Crit Care Med. 2015 Nov 1;192(9):1045-51. doi: 10.1164/rccm.201411-2125CP. Am J Respir Crit Care Med. 2015. PMID: 26177009 Free PMC article.
Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs.
Walkey AJ, Bor J. Walkey AJ, et al. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1399. doi: 10.1164/rccm.201508-1533LE. Am J Respir Crit Care Med. 2015. PMID: 26623693 Free PMC article. No abstract available.

1. Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. Am J Respir Crit Care Med. 2015;192:1045–1051. - PMC - PubMed